Traws Pharma Stock Market Value
| TRAW Stock | 4.58 0.16 3.38% |
| Symbol | Traws |
Traws Pharma Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Traws Pharma. If investors know Traws will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Traws Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.95) | Revenue Per Share 0.01 | Return On Assets (0.53) | Return On Equity (10.97) |
The market value of Traws Pharma is measured differently than its book value, which is the value of Traws that is recorded on the company's balance sheet. Investors also form their own opinion of Traws Pharma's value that differs from its market value or its book value, called intrinsic value, which is Traws Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Traws Pharma's market value can be influenced by many factors that don't directly affect Traws Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Traws Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Traws Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Traws Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Traws Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Traws Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Traws Pharma.
| 06/08/2023 |
| 11/29/2024 |
If you would invest 0.00 in Traws Pharma on June 8, 2023 and sell it all today you would earn a total of 0.00 from holding Traws Pharma or generate 0.0% return on investment in Traws Pharma over 540 days. Traws Pharma is related to or competes with Vera Bradley, Citi Trends, Kontoor Brands, Universal, Keurig Dr, and Diageo PLC. Traws Pharma is entity of United States. It is traded as Stock on NASDAQ exchange. More
Traws Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Traws Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Traws Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 19.63 | |||
| Value At Risk | (8.40) | |||
| Potential Upside | 5.49 |
Traws Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Traws Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Traws Pharma's standard deviation. In reality, there are many statistical measures that can use Traws Pharma historical prices to predict the future Traws Pharma's volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | (2.14) |
Traws Pharma Backtested Returns
Traws Pharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.2, which indicates the firm had a -0.2% return per unit of risk over the last 3 months. Traws Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Traws Pharma's Variance of 22.89, risk adjusted performance of (0.14), and Coefficient Of Variation of (512.00) to confirm the risk estimate we provide. The entity has a beta of 0.44, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Traws Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Traws Pharma is expected to be smaller as well. At this point, Traws Pharma has a negative expected return of -0.96%. Please make sure to validate Traws Pharma's mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and daily balance of power , to decide if Traws Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.84 |
Very good predictability
Traws Pharma has very good predictability. Overlapping area represents the amount of predictability between Traws Pharma time series from 8th of June 2023 to 4th of March 2024 and 4th of March 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Traws Pharma price movement. The serial correlation of 0.84 indicates that around 84.0% of current Traws Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.84 | |
| Spearman Rank Test | 0.66 | |
| Residual Average | 0.0 | |
| Price Variance | 33.71 |
Traws Pharma lagged returns against current returns
Autocorrelation, which is Traws Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Traws Pharma's stock expected returns. We can calculate the autocorrelation of Traws Pharma returns to help us make a trade decision. For example, suppose you find that Traws Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Traws Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Traws Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Traws Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Traws Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Traws Pharma Lagged Returns
When evaluating Traws Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Traws Pharma stock have on its future price. Traws Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Traws Pharma autocorrelation shows the relationship between Traws Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Traws Pharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Traws Stock Analysis
When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.